Compare PASG & PURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PASG | PURR |
|---|---|---|
| Founded | 2017 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 24.9M |
| IPO Year | 2020 | N/A |
| Metric | PASG | PURR |
|---|---|---|
| Price | $15.11 | $3.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $34.50 | $6.58 |
| AVG Volume (30 Days) | 85.2K | ★ 1.2M |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.12 | $3.01 |
| 52 Week High | $20.00 | $4.65 |
| Indicator | PASG | PURR |
|---|---|---|
| Relative Strength Index (RSI) | 54.61 | N/A |
| Support Level | $13.33 | N/A |
| Resistance Level | $20.00 | N/A |
| Average True Range (ATR) | 2.12 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 47.32 | 0.00 |
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.